Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 4,80 M
EBIT 2016 -19,9 M
Net income 2016 -21,8 M
Debt 2016 -
Yield 2016 -
Sales 2017 8,69 M
EBIT 2017 -18,8 M
Net income 2017 -19,1 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 6,66x
Capi. / Sales2017 3,68x
Capitalization 32,0 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy™ acts principally... 
More about the company
Latest news on CYTORI THERAPEUTICS INC
12/06 CYTORI THERAPEUTICS : Sustained Clinical Benefit After 3 Year Follow Up in Scler..
12/05 Cytori to Present at the 9th Annual LD Micro Main Event Conference on Decembe..
12/05 Sustained Clinical Benefit After 3 Year Follow Up in Scleroderma Trial
11/29 Cytori Announces Two Year Follow-Up Published on EU Scleroderma Trial
11/22 CYTORI THERAPEUTICS : Strengthens Global Intellectual Property Portfolio with Ke..
11/21 CYTORI THERAPEUTICS : Cell Therapy™ Leads to Improved Corneal Wound Healin..
11/17 CYTORI THERAPEUTICS : to Present Data in Two Distinct Models of Impaired Wound H..
11/17 CYTORI THERAPEUTICS : Reports Third Quarter 2016 Business and Financial Results
11/10 CYTORI THERAPEUTICS : reports 3Q loss
11/09 CYTORI THERAPEUTICS : Management's Discussion and Analysis of Financial Conditio..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
12/08 MEDTRONIC : China says fines Medtronic local unit 118.5 million yuan for price f..
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue -- 2nd Update
11/22DJMEDTRONIC : Cuts Guidance on Sluggish Revenue
11/15 EXCLUSIVE : EU regulators seen clearing $25 billion Abbott, St Jude deal
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
05/10 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
05/10 Cytori Therapeutics EPS in-line, beats on revenue
05/10 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
05/09 Notable earnings after Tuesday?s close
03/24 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 7,00 $
Spread / Average Target 349%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS IN..-4.14%32
MEDTRONIC PLC-6.31%98 956
BAXTER INTERNATIONAL I..15.54%23 976
ZIMMER BIOMET HOLDINGS..1.81%20 921
C R BARD INC11.48%15 706
HOYA CORPORATION-9.44%15 156
More Results